Cambridge Antibody Technology Group PLC
Summary Details
| ACTIVITIES: | Pharmacuetical research, development and exploitation of products in the field of molecular engineering; Antibody for treatment of rheumatoid arthritis; Antibody for prevention of fibrosis; Tumour Necrosis Therapy; Anti-adipocyte antibody for treatment of Morbid Obesity |
|---|---|
| STATUS: | Full. |
| INDEX: | FTSE Mid 250, techMARK 100 |
| SECTOR: | Pharmaceuticals & Biotechnology |
| NO.EMP: |  (includes five years of historical data) |
| REM: | (current and last financial year) |
| GEARING: | (current and last financial year) |
| ROCE: | (current and last financial year) |
| 1ST QTR: | (current and last financial year) |
| NOTES: | (current and last financial year) |
| denotes that this financial data is available via Hemscott's Premium service |
|
2nd May 2006